← Open Payments lookup

DERICK SONJONG: Open Payments

NPI 1851047690 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,328 in 57 payments from 14 companies in 2025. Trend: 2023 $924 · 2024 $744 · 2025 $1,328

Food & beverage: $1,205Education: $124
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.9$249
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$187
Lundbeck LLC8$141
Alkermes, Inc.9$137
ABBVIE INC.5$116
Neurocrine BioSciences, Inc.4$113
Vanda Pharmaceuticals Inc.4$83
Indivior Inc.3$81
Otsuka America Pharmaceutical, Inc.3$65
E.R. Squibb & Sons, L.L.C.3$61

Products named: CAPLYTA, VRAYLAR, INGREZZA, REXULTI, ABILIFY ASIMTUFII, SUBLOCADE, ARISTADA, HETLIOZ.

Industry payments across MD — which companies pay providers there.